Involvement of intracellular cAMP in epirubicin-induced vascular endothelial cell injury

Takaaki Yamada, Mitsuyo Ueda, Nobuaki Egashira, Nina Zukeyama, Jun Kuwahara, Satohiro Masuda

Research output: Contribution to journalArticlepeer-review

8 Citations (Scopus)


We investigated the involvement of intracellular cAMP in endothelial cell injury induced by epirubicin. Epirubicin-induced decrease in cell viability and increase in caspase-3/7 activity were reversed by a cAMP analog dibutyryl cAMP (DBcAMP) or an activator of adenylate cyclase forskolin concomitant with a phosphodiesterase inhibitor 3-isobutyl-1-methylxanthine. Moreover, epirubicin-induced elevation of lipid peroxide levels was attenuated by DBcAMP. Interestingly, the exposure of epirubicin decreased intracellular cAMP levels before the onset of epirubicin-induced production of lipid peroxidation. These results suggest that intracellular cAMP plays an important role in epirubicin-induced endothelial cell injury.

Original languageEnglish
Pages (from-to)33-37
Number of pages5
JournalJournal of Pharmacological Sciences
Issue number1
Publication statusPublished - Jan 1 2016

All Science Journal Classification (ASJC) codes

  • Molecular Medicine
  • Pharmacology


Dive into the research topics of 'Involvement of intracellular cAMP in epirubicin-induced vascular endothelial cell injury'. Together they form a unique fingerprint.

Cite this